Electric field device tested for tough spinal tumors
NCT ID NCT06906900
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing the safety of two devices (NovoTTF-200M and NovoTTF-200A) that deliver electric fields to treat spinal tumors that have not responded to standard treatments like surgery or radiation. About 30 participants will receive the treatment, either alone or with standard therapy, as long as their doctor believes it is beneficial. The main goal is to see if the devices are safe and to monitor any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NovoTTF-200M and NovoTTF-200A devices (delivering tumor-treating electric fields)
- What this could lead to
- If successful, this could provide a new treatment option for spinal tumors that have not responded to surgery or radiation.
- What could go wrong
- This is a very early Phase 1 trial with only 30 participants, so safety and effectiveness are not yet proven. The treatment may cause side effects or not work as hoped.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas M. D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.